Achieve Life Sciences, Inc. (ACHV)

USD 4.0

(-3.85%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 228 Thousand 236 Thousand 250 Thousand 255 Thousand 254 Thousand 282 Thousand
Gross Profit -228 Thousand -236 Thousand -250 Thousand -255 Thousand -254 Thousand -282 Thousand
Operating Expenses 27.02 Million 40.8 Million 33.09 Million 14.75 Million 16.52 Million 12.81 Million
Selling, General and Administrative Expenses 11.43 Million 10.72 Million 9.12 Million 7.86 Million 6.85 Million 6.94 Million
Research and Development Expenses 15.81 Million 30.07 Million 23.96 Million 6.88 Million 9.67 Million 5.86 Million
Other Expenses - -1.55 Million -58 Thousand -49 Thousand 133 Thousand 126 Thousand
Cost and Expenses 27.25 Million 40.8 Million 33.09 Million 14.75 Million 16.52 Million 12.81 Million
Operating Income -27.25 Million -40.8 Million -33.09 Million -14.75 Million -16.52 Million -12.81 Million
Interest Expense 2.85 Million 1.78 Million - - - -
Income Tax Expense - -475 Thousand -250 Thousand -69 Thousand -254 Thousand -126 Thousand
Earnings before Tax -29.81 Million -42.35 Million -33.15 Million -14.73 Million -16.39 Million -12.68 Million
Net Income -29.81 Million -41.87 Million -32.9 Million -14.66 Million -16.14 Million -12.68 Million
Earnings Per Share Basic -1.50 -3.95 -4.05 -5.39 -39.15 -72.29
Earnings Per Share Diluted -1.50 -3.95 -4.05 -5.39 -39.15 -72.29
Weighted Average Shares Outstanding 19.82 Million 10.59 Million 8.11 Million 2.71 Million 412.32 Thousand 175.51 Thousand
Weighted Average Shares Outstanding (Diluted) 19.82 Million 10.59 Million 8.11 Million 2.71 Million 412.32 Thousand 175.51 Thousand
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -26.73 Million -40.32 Million -32.9 Million -14.47 Million -16.14 Million -12.4 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts